Pune, India

Pradeep Rangrao Patil

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 13.5

ph-index = 1


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Pradeep Rangrao Patil: An Innovator in Pharmacology

Introduction

Pradeep Rangrao Patil, an esteemed inventor based in Maharashtra, India, has made significant contributions to the field of pharmacology. His innovative work focuses on developing compounds that can effectively target diseases associated with voltage-gated sodium channels.

Latest Patents

One of the notable patents attributed to Pradeep Patil is titled "Sulfonamide Compounds as Voltage-Gated Sodium Channel Modulators." This invention details the formulation of sulfonamide compounds defined by a specific structure (Formula I) and their potential applications in treating diseases linked to the inhibition of voltage-gated sodium channels, particularly Na1.7. The patent also encompasses the preparation of these compounds and their pharmaceutically acceptable salts, thereby offering promising pharmaceutical compositions for various disorders.

Career Highlights

Currently, Pradeep Rangrao Patil is associated with Lupin, Inc., a global leader in generic pharmaceuticals. His role involves extensive research and development, pushing boundaries in medicinal chemistry and pharmacology. His dedication to innovation is evident through his focused research on the therapeutic roles of voltage-gated sodium channel modulators.

Collaborations

Throughout his career, Pradeep has collaborated with esteemed colleagues such as Vidya Ramdas and Rajeshkumar Maganlal Loriya. Together, they have worked on advancing research projects aimed at exploring and developing novel medical therapies.

Conclusion

Pradeep Rangrao Patil stands as a testament to the impact that innovative minds can have on medical advancements. His work with sulfonamide compounds showcases the potential of targeted therapies in treating complex diseases. With ongoing collaborations and a firm commitment to research, Patil continues to be a valuable asset to the field of pharmacology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…